This scanning electron microscope image shows SARS-CoV-2 (yellow)—also known as 2019-nCoV, the virus that causes COVID-19—isolated from a patient, emerging from the surface of cells (blue/pink) cultured in the lab. Credit: NIAID-RML

The European Union could approve two coronavirus vaccines being tested by Pfizer-BioNTech and by Moderna before the end of next month, EU Commission president Ursula von der Leyen said Thursday.

Speaking after a video summit of EU leaders, von der Leyen said the European Medicines Agency could give "conditional marketing authorisation,.. as early as the second half of December if all proceeds now without any problem".